Rational design of potent and selective NH-linked aryl/heteroaryl cathepsin K inhibitors

被引:25
作者
Robichaud, J
Bayly, C
Oballa, R
Prasit, P
Mellon, C
Falgueyret, JP
Percival, MD
Wesolowski, G
Rodan, SB
机构
[1] Merck Frosst Ctr Therapeut Res, Dept Med Chem, Kirkland, PQ H9H 3L1, Canada
[2] Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Kirkland, PQ H9H 3L1, Canada
[3] Merck Res Labs, Dept Bone Biol & Osteoporosis Res, West Point, PA USA
关键词
Cathepsin K inhibitors; bone resorption; modelling; biaryl; piperazine;
D O I
10.1016/j.bmcl.2004.05.087
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Prior reports from our laboratories have identified the nonpeptidic inhibitor 2 as a potent and selective Cathepsin K (Cat K) inhibitor. Modelling studies suggested that the introduction of a NH linker between the P3 aryl and P2 leucinamide moieties would allow the formation of a H-bond with the Gly66 residue of Cat K, hopefully increasing potency. Aniline 4 was thus synthesized and showed improved potency over its predecessor 2. Further modelling concluded that a 2-substituted five membered ring could more adequately place the P3 moiety of 4 into the S3 pocket of Cat K. The synthesis of the 2-substituted thiophene 5 confirmed this hypothesis by displaying a slight increase in potency against Cat K (>10-fold increase in potency vs 2) and a good selectivity profile against Cathepsins B, L, and S. This rationally designed inhibitor 5 also displayed increased potency in a functional bone resorption assay (10 nM) versus 2 (95 nM). (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4291 / 4295
页数:5
相关论文
共 13 条
[1]  
Case DA, 1999, AMBER 6
[2]   Practical asymmetric synthesis of a potent cathepsin K inhibitor. Efficient palladium removal following Suzuki coupling [J].
Chen, CY ;
Dagneau, P ;
Grabowski, EJJ ;
Oballa, R ;
O'Shea, P ;
Prasit, P ;
Robichaud, J ;
Tillyer, R ;
Wang, X .
JOURNAL OF ORGANIC CHEMISTRY, 2003, 68 (07) :2633-2638
[3]   Use of X-ray co-crystal structures and molecular modeling to design potent and selective non-peptide inhibitors of cathepsin K [J].
DesJarlais, RL ;
Yamashita, DS ;
Oh, HJ ;
Uzinskas, IN ;
Erhard, KF ;
Allen, AC ;
Haltiwanger, RC ;
Zhao, BG ;
Smith, WW ;
Abdel-Meguid, SS ;
D'Alessio, K ;
Janson, CA ;
McQueney, MS ;
Tomaszek, TA ;
Levy, MA ;
Veber, DF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (35) :9114-9115
[4]   Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L [J].
Falgueyret, JP ;
Oballa, RM ;
Okamoto, O ;
Wesolowski, G ;
Aubin, Y ;
Rydzewski, RM ;
Prasit, P ;
Riendeau, D ;
Rodan, SB ;
Percival, MD .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (01) :94-104
[5]   N-arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B [J].
Greenspan, PD ;
Clark, KL ;
Cowen, SD ;
McQuire, LW ;
Tommasi, RA ;
Farley, DL ;
Quadros, E ;
Coppa, DE ;
Du, ZM ;
Fang, Z ;
Zhou, HH ;
Doughty, J ;
Toscano, KT ;
Wigg, AM ;
Zhou, SY .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) :4121-4124
[6]   Accelerating effect induced by the structure of α-amino acid in the copper-catalyzed coupling reaction of aryl halides with α-amino acids.: Synthesis of benzolactam-V8 [J].
Ma, DW ;
Zhang, YD ;
Yao, JC ;
Wu, SH ;
Tao, FG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (48) :12459-12467
[7]   Crystal structure of human cathepsin K complexed with a potent inhibitor [J].
McGrath, ME ;
Klaus, JL ;
Barnes, MG ;
Bromme, D .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (02) :105-109
[8]  
Motyckova Gabriela, 2002, Current Molecular Medicine (Hilversum), V2, P407, DOI 10.2174/1566524023362401
[9]   A novel class of nonpeptidic biaryl inhibitors of human cathepsin K [J].
Robichaud, J ;
Oballa, R ;
Prasit, P ;
Falgueyret, JP ;
Percival, MD ;
Wesolowski, G ;
Rodan, SB ;
Kimmel, D ;
Johnson, C ;
Bryant, C ;
Venkatraman, S ;
Setti, E ;
Mendonca, R ;
Palmer, JT .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (17) :3709-3727
[10]   NUCLEOPHILIC-SUBSTITUTION REACTIONS OF ALKYL-HALIDES BY USING NEW POLYMER-SUPPORTED REAGENTS CONTAINING HEMIN [J].
SAITO, K ;
HARADA, K .
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1989, 62 (08) :2562-2566